本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ionis Pharmaceuticals, Inc

46.91
-0.3400-0.72%
成交量:53.61萬
成交額:2,515.21萬
市值:77.96億
市盈率:-13.48
高:47.59
開:47.20
低:46.58
收:47.25
52周最高:86.74
52周最低:46.58
股本:1.66億
流通股本:1.62億
量比:1.55
換手率:0.33%
股息:- -
股息率:- -
每股收益(TTM):-3.4800
每股收益(LYR):-2.3812
淨資產收益率:-105.50%
總資產收益率:-12.42%
市淨率:17.73
市盈率(LYR):-19.70

資料載入中...

2024/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/08

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/22

重要事件披露

Form 8-K - Current report